The Anticipation Wrinkle
Today, dopamine seems to be universally regarded as “the reward.” But the dopamine/eating link is also a two-way street.
Is Ozempic the Gateway Drug for CBT?
Two recent studies show nearly twice the weight loss for patients who undergo group CBT in addition to taking liraglutide, a GLP-1 agonist.
Using Lifestyle Medicine to Treat Illness by Changing Behavior
Lifestyle medicine is a six-sided approach to improving lifestyles as a treatment for chronic disease.
BrainWeighve Eating Addiction Telehealth App Expands UCLA Trial
Telehealth provider, eHealth International, expands their UCLA trial of weight loss app, BrainWeighve.
Comedians and Too Much Food
Many professional comedians got their start as fat kids, and served their apprenticeship as obese teenagers, and some have carried it into adulthood.
GLP-1 Drugs Used to Reduce Cancer, Fight Dementia
GLP-1 agonists such as Ozempic and Wegovy are being tested for their ability to impact cancer rates and slow dementia.